Heligenics Overview
- Status
- Private
- Employees
- 10

- Latest Deal Type
- Angel
- Latest Deal Amount
- $1.18M

- Investors
- 1
Heligenics General Information
Description
Developer of a medicinal drug intended to prevent disease and heal patients afflicted with illness through genomics. The company's platform revolutionize genetic testing and drug discovery through determining the function of genetic variation, can comprehensively measure the functional significance of naturally occurring mutations in the human genome, enhancing the accuracy of genetic testing whether for rare disease or cancer, enabling medical industry to get an enhanced genetic test interpretation and the pharmaceutical companies to empower conversion of generic drugs into targeted precision medicines.
Contact Information
- 833 Las Vegas Boulevard North
- Las Vegas, NV 89101
- United States
Heligenics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Angel (individual) | 15-Dec-2020 | $1.18M | 00.000 | Completed | Generating Revenue | |
1. Grant | 01-Jan-2015 | 00.00 | Completed | Generating Revenue |
Heligenics Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Martin Schiller | Founder, Chief Executive Officer & Chairman | ||
Lawrence Loomis | Chief Operating Officer, Corporate Secretary & Board Member |
Heligenics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialHeligenics Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Nevada Governor's Office of Economic Development | Government | 000 0000 | 000000 0 |